Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

Share Price is delayed by 15 minutes
Get Live Data
2,209.00    19.00 (0.87%)
Bid:
2,212.00
Ask:
2,214.00
Spread: 2.00 (0.09%)
Market Cap: £22.41b
III Live PriceLast checked at - London Stock Exchange

Intraday 3i Group Share Chart

Interim Management Statement

26 Jan 2012 07:00

RNS Number : 1951W
3i Group PLC
26 January 2012
 



26 January 2012

 

 

 

3i Group plc - Interim Management Statement

 

 

3i Group plc ("3i"), the international private equity firm, today issues its Interim Management Statement in accordance with FSA Disclosure and Transparency Rule 4.3. This statement which, as usual, is unaudited, relates to the three month period from 30 September 2011 to 31 December 2011.

 

Michael Queen, 3i's Chief Executive, said: "We have made a number of important strategic steps to strengthen each of our business lines in the period, including the reorganisation of our private equity business, signing our first investment in Brazil, and the launch of our Credit Opportunities Fund."

 

"We have also generated good realisations from the portfolio, although, as we said in our November half-year results announcement, the operating environment is challenging given the deterioration in the macro-economic outlook and continued market uncertainty. Conditions have not improved since then, which has been reflected in a softening in the earnings performance of some of the portfolio over this period."

 

 

1. Investment

Investment by business line was as follows:

 

Investment (£m)

 

Six months ended

Three months ended

Nine months to

Nine months to

30 September

31 December

31 December

31 December

2011

2011

2011 (total)

2010 (total)

Private Equity

Buyouts

292

65

357

436

Growth Capital

117

4

121

23

Infrastructure

33

-

33

15

Debt Management

6

13

19

36

Total

448

82

530

510

 

 

2. Realisations

 

Realisations by business line were as follows:

Realisations (£m)

 

Six months ended

Three months ended

Nine months to

Nine months to

30 September

31 December

31 December

31 December

2011

2011

2011 (total)

2010 (total)

Private Equity

Buyouts

360

202

562

168

Growth Capital

163

16

179

126

Infrastructure

1

-

1

1

Debt Management

-

-

-

40

Non-core

8

1

9

63

Total

532

219

751

398

 

 

3. Cashflow and balance sheet

 

The Group had cash, cash deposits and undrawn committed facilities of £1,753 million as at 31 December 2011 (30 September 2011: £1,680 million) and gross debt had reduced to £1,659 million (30 September 2011: £1,722 million).

 

Net cash divestment in the three month period was £159 million and net debt decreased by £136 million to £395 million (30 September 2011: £531 million).

 

 

 

Ends

 

For information please contact:

 

Patrick Dunne

Group Communications Director, 3i Group plc

020 7975 3566

 

Kathryn van der Kroft

PR Director

020 7975 3021

 

 

 

 

This statement aims to give an indication of material events and transactions that have taken place during the period from 30 September 2011 to 31 December 2011 and their impact on the financial position of 3i Group plc. These indications reflect the Board's current view. They are subject to a number of risks and uncertainties and could change. Factors which could cause or contribute to such differences include, but are not limited to, general economic and market conditions and specific factors affecting the financial prospects or performance of individual investments within 3i's portfolio.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBAMRTMBJTBLT
Date   Source Headline
19th May 202111:56 amRNSDoc re. 2021 Annual Report and Accounts
13th May 20217:00 amRNSDirectorate Change
13th May 20217:00 amRNSResults for the year to 31 March 2021
30th Apr 20214:09 pmRNSTotal Voting Rights
30th Apr 20214:07 pmRNSDirector/PDMR Shareholding
1st Apr 202110:01 amRNSDirector Declaration
1st Apr 20218:39 amRNSPortfolio Update
31st Mar 20214:50 pmRNSTotal Voting Rights
31st Mar 20214:45 pmRNSDirector/PDMR Shareholding
19th Mar 20213:05 pmRNSDirector Declaration
18th Mar 20217:00 amRNSAction Capital Markets Seminar & portfolio update
1st Mar 20214:51 pmRNSDirector/PDMR Shareholding
26th Feb 20212:40 pmRNSTotal Voting Rights
26th Feb 20212:37 pmRNSDirector/PDMR Shareholding
8th Feb 20214:57 pmRNSDirector/PDMR Shareholding
29th Jan 20214:30 pmRNSTotal Voting Rights
29th Jan 20214:29 pmRNSDirector/PDMR Shareholding
28th Jan 20217:00 amRNSQ3 Performance update
5th Jan 20213:13 pmRNSTotal Voting Rights
5th Jan 20213:10 pmRNSDirector/PDMR Shareholding
5th Jan 20211:52 pmRNSPortfolio Update
21st Dec 202011:58 amRNSHolding(s) in Company - Replacement
21st Dec 202010:38 amRNSHolding(s) in Company
18th Dec 20209:03 amRNSDirector Declaration
17th Dec 20202:58 pmRNSDirectorate Change
16th Dec 20205:04 pmRNSDirector/PDMR Shareholding
11th Dec 20208:28 amRNSDirectorate Change
10th Dec 20202:21 pmRNSBlock listing Interim Review
30th Nov 20202:20 pmRNSDirector/PDMR Shareholding
30th Nov 20202:20 pmRNSTotal Voting Rights
12th Nov 202011:35 amRNSDoc re. Half Yearly Report 2020
12th Nov 20207:00 amRNSHalf-year Report
30th Oct 20201:56 pmRNSTotal Voting Rights
30th Oct 20201:54 pmRNSDirector/PDMR Shareholding
1st Oct 20201:46 pmRNSPortfolio Update
30th Sep 20205:25 pmRNSTotal Voting Rights
30th Sep 20205:23 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSPortfolio update and Capital Markets Seminar
8th Sep 20202:28 pmRNSDirector/PDMR Shareholding
28th Aug 20202:50 pmRNSTotal Voting Rights
28th Aug 20202:47 pmRNSDirector/PDMR Shareholding
4th Aug 20202:36 pmRNSDirector/PDMR Shareholding
31st Jul 20203:41 pmRNSTotal Voting Rights
31st Jul 20202:40 pmRNSDirector/PDMR Shareholding
30th Jul 20207:00 amRNSQ1 performance update
16th Jul 20202:22 pmRNSPortfolio Update
1st Jul 20203:00 pmRNSDirector/PDMR Shareholding
30th Jun 20204:17 pmRNSTotal Voting Rights
30th Jun 20204:17 pmRNSDirector/PDMR Shareholding
30th Jun 20202:08 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.